DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine

Abstract

To address the need for vaccine platforms that induce robust cell-mediated immunity, we investigated the potential of utilizing self-assembling biologic nanolipoprotein particles (NLPs) as an antigen and adjuvant delivery system to induce antigen-specific murine T cell responses. Here, we utilized OT-I and OT-II TCR-transgenic mice to investigate the effects of NLP-mediated delivery of the model antigen ovalbumin (OVA) on T cell activation. Delivery of OVA with the TLR4 agonist monophosphoryl lipid A (MPLA) in the context of NLPs significantly enhanced the activation of both CD4+ and CD8+ T cells in vitro compared to co-administration of free OVA and MPLA. Upon intranasal immunization of mice harboring TCR-transgenic cells, NLPs enhanced the adjuvant effects of MPLA and the in vivo delivery of OVA, leading to significantly increased expansion of CD4+ and CD8+ T cells in lung-draining lymph nodes. Therefore, NLPs are a promising vaccine platform for inducing T cell responses following intranasal administration.

Authors:
 [1];  [1];  [1];  [1];  [1];  [2];  [2];  [1];  [2];  [1]
  1. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States). Biosciences and Biotechnology Division
  2. Loyola Univ. Medical Center, Maywood, IL (United States). Dept. of Microbiology & Immunology
Publication Date:
Research Org.:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Org.:
USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research
OSTI Identifier:
1409999
Alternate Identifier(s):
OSTI ID: 1397843
Report Number(s):
LLNL-JRNL-724260
Journal ID: ISSN 0264-410X
Grant/Contract Number:  
AC52-07NA27344
Resource Type:
Accepted Manuscript
Journal Name:
Vaccine
Additional Journal Information:
Journal Volume: 35; Journal Issue: 11; Journal ID: ISSN 0264-410X
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 77 NANOSCIENCE AND NANOTECHNOLOGY; Nanolipoprotein; Nanoparticle; Intranasal; Vaccine; T cell activation; Nanodisc

Citation Formats

Weilhammer, Dina, Dunkle, Alexis D., Blanchette, Craig D., Fischer, Nicholas O., Corzett, Michele, Lehmann, Doerte, Boone, Tyler, Hoeprich, Paul, Driks, Adam, and Rasley, Amy. Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine. United States: N. p., 2017. Web. doi:10.1016/j.vaccine.2017.02.004.
Weilhammer, Dina, Dunkle, Alexis D., Blanchette, Craig D., Fischer, Nicholas O., Corzett, Michele, Lehmann, Doerte, Boone, Tyler, Hoeprich, Paul, Driks, Adam, & Rasley, Amy. Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine. United States. https://doi.org/10.1016/j.vaccine.2017.02.004
Weilhammer, Dina, Dunkle, Alexis D., Blanchette, Craig D., Fischer, Nicholas O., Corzett, Michele, Lehmann, Doerte, Boone, Tyler, Hoeprich, Paul, Driks, Adam, and Rasley, Amy. Tue . "Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine". United States. https://doi.org/10.1016/j.vaccine.2017.02.004. https://www.osti.gov/servlets/purl/1409999.
@article{osti_1409999,
title = {Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine},
author = {Weilhammer, Dina and Dunkle, Alexis D. and Blanchette, Craig D. and Fischer, Nicholas O. and Corzett, Michele and Lehmann, Doerte and Boone, Tyler and Hoeprich, Paul and Driks, Adam and Rasley, Amy},
abstractNote = {To address the need for vaccine platforms that induce robust cell-mediated immunity, we investigated the potential of utilizing self-assembling biologic nanolipoprotein particles (NLPs) as an antigen and adjuvant delivery system to induce antigen-specific murine T cell responses. Here, we utilized OT-I and OT-II TCR-transgenic mice to investigate the effects of NLP-mediated delivery of the model antigen ovalbumin (OVA) on T cell activation. Delivery of OVA with the TLR4 agonist monophosphoryl lipid A (MPLA) in the context of NLPs significantly enhanced the activation of both CD4+ and CD8+ T cells in vitro compared to co-administration of free OVA and MPLA. Upon intranasal immunization of mice harboring TCR-transgenic cells, NLPs enhanced the adjuvant effects of MPLA and the in vivo delivery of OVA, leading to significantly increased expansion of CD4+ and CD8+ T cells in lung-draining lymph nodes. Therefore, NLPs are a promising vaccine platform for inducing T cell responses following intranasal administration.},
doi = {10.1016/j.vaccine.2017.02.004},
journal = {Vaccine},
number = 11,
volume = 35,
place = {United States},
year = {Tue Feb 14 00:00:00 EST 2017},
month = {Tue Feb 14 00:00:00 EST 2017}
}

Journal Article:

Citation Metrics:
Cited by: 13 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

T-cell-inducing vaccines - what’s the future: T-cell vaccines
journal, December 2011


New horizons in adjuvants for vaccine development
journal, January 2009

  • Reed, Steven G.; Bertholet, Sylvie; Coler, Rhea N.
  • Trends in Immunology, Vol. 30, Issue 1
  • DOI: 10.1016/j.it.2008.09.006

Vaccine adjuvants revisited
journal, May 2007


Micro and Nanoparticle-Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective
journal, December 2012


Nanoparticle vaccines
journal, January 2014


Enhancement of Dendritic Cell Antigen Cross-Presentation by CpG DNA Involves Type I IFN and Stabilization of Class I MHC mRNA
journal, August 2005


Evaluation of Nanolipoprotein Particles (NLPs) as an In Vivo Delivery Platform
journal, March 2014


The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge
journal, December 2013


Colocalized Delivery of Adjuvant and Antigen Using Nanolipoprotein Particles Enhances the Immune Response to Recombinant Antigens
journal, January 2013

  • Fischer, Nicholas O.; Rasley, Amy; Corzett, Michele
  • Journal of the American Chemical Society, Vol. 135, Issue 6
  • DOI: 10.1021/ja3063293

pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides
journal, April 2013

  • Wilson, John T.; Keller, Salka; Manganiello, Matthew J.
  • ACS Nano, Vol. 7, Issue 5
  • DOI: 10.1021/nn305466z

Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization
journal, December 2012


Characterization and Purification of Polydisperse Reconstituted Lipoproteins and Nanolipoprotein Particles
journal, July 2009

  • Blanchette, Craig; Segelke, Brent; Fischer, Nicholas
  • International Journal of Molecular Sciences, Vol. 10, Issue 7
  • DOI: 10.3390/ijms10072958

Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations
journal, April 2008

  • Blanchette, Craig D.; Law, Richard; Benner, W. Henry
  • Journal of Lipid Research, Vol. 49, Issue 7
  • DOI: 10.1194/jlr.M700586-JLR200

Kinetic Analysis of His-Tagged Protein Binding to Nickel-Chelating Nanolipoprotein Particles
journal, July 2010

  • Blanchette, Craig D.; Fischer, Nicholas O.; Corzett, Michele
  • Bioconjugate Chemistry, Vol. 21, Issue 7
  • DOI: 10.1021/bc100129s

Immobilization of His-Tagged Proteins on Nickel-Chelating Nanolipoprotein Particles
journal, March 2009

  • Fischer, Nicholas O.; Blanchette, Craig D.; Chromy, Brett A.
  • Bioconjugate Chemistry, Vol. 20, Issue 3
  • DOI: 10.1021/bc8003155

Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
journal, April 2010


Expanding antigen-specific regulatory networks to treat autoimmunity
journal, February 2016

  • Clemente-Casares, Xavier; Blanco, Jesus; Ambalavanan, Poornima
  • Nature, Vol. 530, Issue 7591
  • DOI: 10.1038/nature16962

Repressing Immunity in Autoimmune Disease
journal, May 2016


TLR and Nucleotide-Binding Oligomerization Domain-like Receptor Signals Differentially Regulate Exogenous Antigen Presentation
journal, December 2011


Antigen delivery by α 2 -macroglobulin enhances the cytotoxic T lymphocyte response
journal, August 2009

  • Bowers, Edith V.; Horvath, Jeffrey J.; Bond, Jennifer E.
  • Journal of Leukocyte Biology, Vol. 86, Issue 5
  • DOI: 10.1189/jlb.1008653

The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC-205/CD205 Receptor on Dendritic Cells
journal, September 2009


Works referencing / citing this record:

Lipid composition dictates serum stability of reconstituted high-density lipoproteins: implications for in vivo applications
journal, January 2018

  • Gilmore, Sean F.; Carpenter, Timothy S.; Ingólfsson, Helgi I.
  • Nanoscale, Vol. 10, Issue 16
  • DOI: 10.1039/c7nr09690a

Extent of MHC Clustering Regulates Selectivity and Effectiveness of T Cell Responses
journal, December 2018

  • Anikeeva, Nadia; Fischer, Nicholas O.; Blanchette, Craig D.
  • The Journal of Immunology, Vol. 202, Issue 2
  • DOI: 10.4049/jimmunol.1801196